Abstract
Background: Attempts to quantify effect sizes of non-pharmaceutical interventions (NPI) to control COVID-19 in the US have not accounted for heterogeneity in social or environmental factors that may influence NPI effectiveness. This study quantifies national and sub-national effect sizes of NPIs during the early months of the pandemic in the US.Methods: Daily county-level COVID-19 cases and deaths during the first wave (January 2020 through phased removal of interventions) were obtained. County-level cases, doubling times, and death rates were compared to four increasingly restrictive NPI levels. Socio-demographic, climate and mobility factors were analyzed to explain and evaluate NPI heterogeneity, with mobility used to approximate NPI compliance. Analyses were conducted separately for the US and for each Census regions (Pacific, Mountain, east/West North Central, East/West South Central, South Atlantic, Middle Atlantic and New England). A stepped-wedge cluster-randomized trial analysis was used, leveraging the phased implementation of policies.Results: Aggressive (level 4) NPIs were associated with slower COVID-19 propagation, particularly in high compliance counties. Longer duration of level 4 NPIs was associated with lower case rates (log beta −0.028, 95% CI −0.04 to −0.02) and longer doubling times (log beta 0.02, 95% CI 0.01–0.03). Effects varied by Census region, for example, level 4 effects on doubling time in Pacific states were opposite to those in Middle Atlantic and New England states. NPI heterogeneity can be explained by differential timing of policy initiation and by variable socio-demographic county characteristics that predict compliance, particularly poverty and racial/ethnic population. Climate exhibits relatively consistent relationships across Census regions, for example, higher minimum temperature and specific humidity were associated with lower doubling times and higher death rates for this period of analysis in South Central, South Atlantic, Middle Atlantic, and New England states.Conclusion and Relevance: Heterogeneity exists in both the effectiveness of NPIs across US Census regions and policy compliance. This county-level variability indicates that control strategies are best designed at community-levels where policies can be tuned based on knowledge of local disparities and compliance with public health ordinances.
Highlights
During the first COVID-19 wave (15th January to 31th May 2020), the disease spread rapidly across the globe, infecting over 3 million people with the SARS-CoV-2 virus
In these later three regions, the first COVID-19 case was detected an average of 10 days prior to North and South Central states
This study evaluates the effectiveness of four non-pharmaceutical intervention categories on COVID-19 case rates, doubling time, and deaths at the county level in the US, and the heterogeneity that exists across Census regions
Summary
During the first COVID-19 wave (15th January to 31th May 2020), the disease spread rapidly across the globe, infecting over 3 million people with the SARS-CoV-2 virus. No official US policy existed to prevent COVID-19 transmission until January 31, 2020, when a presidential order blocked the entry of non-US citizens into the US traveling from China. The state of Washington declared the first State of Emergency (February 29), followed by California (March 4) and Maryland (March 5); many counties implemented restrictive policies prior to state action. Three counties in Washington (King, Pierce, Snohomish) and four in Arkansas (Grant, Jefferson, Pulaski, Saline) ordered school closings on March 12 vs statewide closures on March 17; counties in Pennsylvania, California, and New Jersey closed non-essential businesses prior to the state; and counties in California and Idaho issued restrictions on mass gatherings before state policies. Attempts to quantify effect sizes of non-pharmaceutical interventions (NPI) to control COVID-19 in the US have not accounted for heterogeneity in social or environmental factors that may influence NPI effectiveness.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
